Since VHL-PHEOs/PGLs have a better prognosis than SDHB-PHEOs/PGLs, the difference in HK2 does not seem to contribute to their distinct tumor aggressiveness in these particular tumors. The gene discussed is HK2; the disease is neoplasm.